follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      Home2021May

      Month: May 2021

      Tech

      Cimpress (CMPR) Up 2.5% Since Last Earnings Report: Can It Continue?

      May 28
      It has been about a month since the last earnings report for Cimpress (CMPR). Shares have added about 2.5% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ... [Read]
      Biotechnology

      35 of the Best Ideas Companies to Present at the Summer Solstice – Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021

      May 27
      RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice – Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be ... [Read]
      pharmaceuticals
      Biotechnology

      Citius Pharmaceuticals, Inc. Announces Appointment of Ilanit Allen as Vice President, Corporate Communications and Investor Relations

      May 17
      Citius Pharmaceuticals Expands Management Team to Support Anticipated Milestones and Business Growth PR Newswire CRANFORD, N.J. , May 17, 2021 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR) today announced that Ilanit ... [Read]
      Editorspicks

      MindMed Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial

      May 17 MindMed Inc.
      MindMed Finalizes Clinical Development Approach for LSD Targeting Generalized Anxiety Disorder as Initial Indication NEW YORK, May 17, 2021 /CNW/ — Mind Medicine (MindMed) Inc. (NEO: MMED)(DE: BGHM)(OTCQB:MNMD) (“MindMed” or the “Company”), a leading clinical-stage psychedelic ... [Read]
      psychedelics
      Biotechnology

      Psychedelics Move to The Forefront of Innovative Research as the FDA Approves Large-Scale Testing

      May 14 microsmallcap
      Psychedelics are quietly being used in clinical settings on small numbers of patients, but they are moving quickly toward medical approval. The FDA recently approved large-scale human trials to determine whether MDMA and other psychedelics ... [Read]
      Health

      Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates

      May 13
      Aspira (AWH) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.04 per share a year ago. These figures ... [Read]
      Carebook Technologies Inc

      Carebook Technologies to Report First Quarter Results

      May 13 Carebook Technologies Inc
      MONTREAL, May 13, 2021 /CNW/ – Carebook Technologies Inc.  (TSXV:CRBK)(OTCPK:CRBKF)(FRANKFURT: PMM1)(“Carebook” or the “Company“), a leading Canadian digital health company offering innovative digital health and virtual care solutions for pharmacies, employers and insurers, will release its ... [Read]
      Editorspicks

      Hello Pal Announces $2.494 Million Monthly Revenue for April 2021

      May 13 Hello Pal International
      VANCOUVER, BC, May 13, 2021 /PRNewswire/ — Hello Pal International Inc. (CSE:HP)(OTC:HLLPF)(Frankfurt: 27H)(“Hello Pal” or the “Company”), a provider of rapidly growing international live-streaming, language learning and social-crypto platform, is pleased to announce that it achieved 13,140,757 ... [Read]
      Editorspicks

      Hello Pal Announces Closing of C$7.25 Million Subscription Receipt Financing

      May 12 Hello Pal International
        VANCOUVER, BC, May 12, 2021 /PRNewswire/ — Hello Pal International Inc. (CSE:HP)(OTC:HLLPF)(Frankfurt: 27H)(“Hello Pal” or the “Company”), a provider of an international live-streaming, language learning and social-crypto platform, is pleased to announce that it has ... [Read]
      health

      Else Nutrition Set to Bolster Northwest Distribution with Launch of Plant-Based Toddler Nutrition at Haggen Food & Pharmacy

      May 11 Else Nutrition Holdings Inc.
      VANCOUVER, BC, May 10, 2021 /PRNewswire/ – Else Nutrition Holdings Inc. (TSX.V:BABY) (OTCQB:BABYF) (FSE:0YL) (“Else” or the “Company”) the Plant-Based baby, toddler, and children nutrition company, announces it will expand the distribution of its Plant-Based Complete Nutrition drink for Toddlers ... [Read]

      Posts pagination

      1 2 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get FREE Cimpress plc Email Alerts
      Get FREE Cimpress plc Email Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x